HUSSEIN TAWBI to Carboplatin
This is a "connection" page, showing publications HUSSEIN TAWBI has written about Carboplatin.
Connection Strength
0.080
-
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620). Breast Cancer Res Treat. 2023 Apr; 198(3):487-498.
Score: 0.045
-
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies. Cancer Chemother Pharmacol. 2019 12; 84(6):1289-1301.
Score: 0.035